相关实验视频
Updated: Jun 12, 2025

Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
在正常和白血病干细胞中的代谢调节
Cheuk-Him Man1, Changzheng Li2, Xi Xu3
1Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China; Key Laboratory of Stem Cells and Tissue Engineering (Ministry of Education), Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.
代谢途径调节血造干细胞 (HSC) 和白血病干细胞 (LSC) 中的压力. 针对这些代谢适应,通过克服化学抵抗和免疫逃避,为白血病提供新的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
- 代谢过程中的代谢.
背景情况:
- 造血干细胞 (HSCs) 维持血细胞的生产和组织的稳态.
- 白血病干细胞 (LSCs) 驱动白血病的进展,并且往往对治疗有抗性.
- 代谢适应越来越被认为是干细胞功能的关键调节者.
研究的目的:
- 审查代谢途径如何影响在恒温和衰老过程中HSC中的氧化和蛋白质静态压力.
- 探索LSC中可向的代谢途径,重点关注它们与表观遗传学和微观环境的相互作用.
- 讨论HSC和LSC之间的代谢差异对治疗的影响.
主要方法:
- 关于干细胞代谢的最新研究的文献综述.
- 分析调节高血压细胞应激反应的代谢途径.
- 检查与化学抵抗和免疫逃避有关的LSC代谢适应.
主要成果:
- 代谢途径在衰老过程中显著影响HSC功能,生存和应激反应.
- 在LSC中可向的代谢途径与表观遗传和微环境因素相互作用.
- 代谢重编程有助于LCS化学抵抗和免疫逃避.
结论:
- 代谢适应是HSC和LSC功能的关键决定因素.
- 准代谢途径为白血病提供了一个有希望的治疗途径.
- 了解HSC-LSC代谢差异对于开发有效的癌症治疗是至关重要的.
相关概念视频
Regulation of Hematopoietic Stem Cells
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Differentiation of Common Myeloid Progenitor Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

